Analgesic nanomedicines for the treatment of chronic pain

Hao Liu, Hongjun Zhuang, Ya Wang, Yuen Yee Cheng, Feixiang Chen, Jian Chen, Xinglei Song, Run Zhang, Yanyan Liu, Wenbo Bu

PDF
BMEMat ›› 2024, Vol. 2 ›› Issue (1) : 12049. DOI: 10.1002/bmm2.12049
REVIEW

Analgesic nanomedicines for the treatment of chronic pain

Author information +
History +

Abstract

Chronic pain is a major cause of suffering that often accompanies diseases and therapies, affecting approximately 20% of individuals at some point in their lives. However, current treatment modalities, such as anesthetic and antipyretic analgesics, have limitations in terms of efficacy and side effects. Nanomedical technology offers a promising avenue to overcome these challenges and introduce new therapeutic mechanisms. This article reviews the recent research on nanomedicine analgesics, integrating analyses of neuroplasticity changes in neurons and pathways related to the transition from acute to chronic pain. Furthermore, it explores potential future strategies using nanomaterials, aiming to provide a roadmap for new analgesic development and improved clinical pain management. By leveraging nanotechnology, these approaches hold the potential to revolutionize pain treatment by delivering targeted and effective relief while minimizing side effects.

Keywords

analgesics / chronic pain / local anesthetics / nanomedicine / neuroplasticity

Cite this article

Download citation ▾
Hao Liu, Hongjun Zhuang, Ya Wang, Yuen Yee Cheng, Feixiang Chen, Jian Chen, Xinglei Song, Run Zhang, Yanyan Liu, Wenbo Bu. Analgesic nanomedicines for the treatment of chronic pain. BMEMat, 2024, 2(1): 12049 https://doi.org/10.1002/bmm2.12049

RIGHTS & PERMISSIONS

2023 2023 The Authors. BMEMat published by John Wiley & Sons Australia, Ltd on behalf of Shandong University.
PDF

Accesses

Citations

Detail

Sections
Recommended

/